0001645460 2026-03-16 2026-03-16 0001645460 1 2026-03-16 2026-03-16 0001645460 2 2026-03-16 2026-03-16 0001645460 3 2026-03-16 2026-03-16 0001645460 4 2026-03-16 2026-03-16 0001645460 5 2026-03-16 2026-03-16 0001645460 6 2026-03-16 2026-03-16 0001645460 7 2026-03-16 2026-03-16 iso4217:USD pure S-3 S-3 EX-FILING FEES 0001645460 Cue Biopharma, Inc. N/A N/A 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 S-3 Cue Biopharma, Inc. Debt Debt Securities true Equity Common Stock, $0.001 par value per share true Equity Preferred Stock, $0.001 par value per share true Other Subscription Rights true Other Units true Other Warrants true false Unallocated (Universal) Shelf true 300000000.00 0.0001381 41430.00 300000000.00 41430.00 0.00 0.00 41430.00 (1) Pursuant to Instruction 2.A(iii)(b) of Item 16(b) of Form S-3, this information is not required to be included. An indeterminate amount of the securities of each identified class is being registered as may from time to time be offered under this registration statement at indeterminate prices, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold under this registration statement, as shall have an aggregate initial offering price up to $300,000,000. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. In addition, the total amount to be registered and the proposed maximum aggregate offering price are estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act. (2) Units may be issued under a unit agreement and will represent an interest in one or more securities registered under this registration statement including shares of common stock or preferred stock, debt securities or warrants, in any combination, which may or may not be separable from one another.